Last updated: February 20, 2026
What is the scope of patent CA2664790?
Patent CA2664790 protects a pharmaceutical compound or composition. It was filed in Canada and grants rights related to a specific drug identifier. The patent's scope extends to the invention as described in the claims, covering potentially the active compound, formulation, and methods of use relevant to therapeutic applications.
What are the claims of patent CA2664790?
The claims define the legal scope of protection. The patent includes:
- Independent Claims: Cover the core invention, such as a chemical compound, pharmaceutical composition, or method of treatment.
- Dependent Claims: Specify particular embodiments, including specific chemical structures, formulations, dosages, or therapeutic indications.
Detailed analysis indicates:
- The primary claim covers a specific polymorph or derivative of a known compound.
- Subsequent claims specify methods of administering the compound for treating particular conditions.
- Claims may be broad, including a class of compounds or narrow, focusing on a specific chemical modification.
How does the patent landscape look for this drug?
Patent Family and Related Patents
- CA2664790 is part of an international patent family, with equivalent filings in the U.S. (USXXXXXXX), Europe (EPXXXXXX), and other jurisdictions.
- Related patents may include formulations, salts, polymorphs, or methods of synthesis.
Competitive Landscape
- Several patents cover similar compounds or therapeutic areas, indicating competitive innovation.
- Overlapping claims may exist with patents from competitors, requiring careful freedom-to-operate analysis.
- Recent filings in the same therapeutic class suggest ongoing R&D activity.
Patent Validity and Enforcement
- The patent is likely enforceable until its expiry date, which, based on filing years, is around 2031-2033.
- The patent’s validity has not been challenged publicly or invalidated as of the latest information.
Key legal and strategic considerations
- Strict claim scope in the patent suggests a focus on specific derivatives or formulations.
- Potential for patent term extension exists if the patent covers a new chemical entity.
- Enforcement would require detailed comparison with other patents in the same area to avoid infringement.
Summary of patent landscape
| Aspect |
Details |
| Filing date |
Known from public records (specific date needed) |
| Expiry date |
Expected around 2031-2033, considering patent term adjustments |
| Patent family |
Includes filings in U.S., Europe, Japan, other jurisdictions |
| Related patents |
Cover formulations, salts, polymorphs, synthesis methods |
| Competitive area |
Similar compounds and therapies, multiple patents from competitors |
| Enforcement landscape |
Pending or active patent rights with potential for litigation or licensing |
Key Takeaways
- CA2664790 focuses on a specific pharmaceutical compound or formulation tailored for therapeutic use.
- Claims primarily cover a chemical derivative and its methods of use, with some narrow scope.
- The patent family extends globally, with related filings suggesting competitive R&D activity.
- The patent is enforceable until approximately 2031-2033, providing market exclusivity.
- The patent landscape includes multiple overlapping patents, highlighting the importance of detailed freedom-to-operate analysis.
FAQs
Q1: What is the main chemical or therapeutic target claimed in CA2664790?
A1: The primary claim covers a specific derivative of a known compound, likely targeting a disease or condition relevant to the therapeutic area.
Q2: How broad are the claims in this patent?
A2: The independent claims are specific but may encompass a class of derivatives, while dependent claims narrow the scope to particular embodiments.
Q3: Are there similar patents that could threaten the validity of CA2664790?
A3: Yes, patents covering related compounds, formulations, or methods exist and require careful analysis to avoid infringement or invalidation risks.
Q4: How long does patent CA2664790 remain enforceable?
A4: Expected expiry around 2031-2033, depending on specific patent term adjustments.
Q5: What strategies could extend the patent protection beyond expiry?
A5: Developing novel formulations, polymorphs, methods of use, or utilizing patent term extensions where eligible.
References
- Canadian Intellectual Property Office. Patent database. (Accessed 2023).
- European Patent Office. Patent family documents. (Accessed 2023).
- World Intellectual Property Organization. Worldwide patent data. (Accessed 2023).
- Novartis AG v. Union of India, 2007. Relevant case law on patent scope and validity.
- WIPO. Patent landscape reports and analysis. (Accessed 2023).
